ViiV Healthcare
Owners:
GlaxoSmithKline
Owners
A number of medicines of the company is included in the list of vital and essential drugs and also in the schemes of treatment of HIV infection recommended by World Health Organization. Occupies about 19% of the world market of production of medicines for treatment of HIV infections. ViiV Healthcare invests in localization of production of a number of the key medicines in [1] and also in scientific research (in Moscow and 19 other centers in Russia 10 researches of ViiV Healthcare company are performed).
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |